General assembly of Decision4Liver. After 3.5 yrs, results of omics in acute decompensation of cirrhosis (PREDICT & ACARA) are in: ✅whole blood transcriptomics ✅epigenomics ✅metabolomics and inflammatory mediators ✅extracellular vesicles ✅microRNA Next 🟰 multiomics‼️

▶️ Now! Pr Pierre-Emmanuel Rautou, the LIVER-TRACK coordinator is giving a talk The Liver Week in Korea 🇰🇷 Rautou Pierre-Emmanuel #Theliverweek #LIVERTRACK #Hepatology #Liver

🟪NEW Article in press❕ Link between persistent, unexplained gammaGT elevation and Porto-Sinusoidal Vascular Disorder 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PSVD

📢EASL proudly announces the appointment of Prof. Vlad Ratziu as the new Editor-in-Chief of the Journal of Hepatology: the premier publication in the field of liver research. "With the ultimate aim to serve academic research, we will strive to select, improve upon and disseminate the

We are thrilled to announce Prof. Vlad Ratziu as the new Editor-in-Chief of Journal of Hepatology, starting January 2025! Joining him: ➡️Deputy Editors: Annalisa Berzigotti & Frank Tacke ➡️Co-Editors: Tom H. Karlsen, Lorenza Rimassa, & Heiner Wedemeyer ➡️Senior Editor: Philip Newsome EASLnews

#SneakPeek! Let's continue exploring the upcoming special edition on #ACLF in #Liver Int! 6️⃣th review: S Valainathan, Q Xie, V Arroyo, PE Rautou (Rautou Pierre-Emmanuel) Prognosis algorithms for acute decompensation of #cirrhosis and ACLF. Liver Int 2024 🔓 onlinelibrary.wiley.com/doi/10.1111/li… @EF_clif

📢🆕 Valdig Group study just out in HEPATOLOGY Journal Want to spare endoscopies in patients with PSVD❓ Spleen stiffness measurement < 40 kPa ➕ serum bilirubin < 1 mg/dL 🟰 < 5% of high risk varices ➡️ 21 to 38 % of endoscopies can be avoided journals.lww.com/hep/abstract/9…

🔈 BIG NEWS! We’ve enrolled the first patient at Hôpital Beaujon, Clichy, France in the #COMBATtrial, a multicenter, randomized, open-label, #PhaseII #clinicaltrial. Read more in our press release: decision-for-liver.eu/wp-content/upl… #LiverTwitter Rautou Pierre-Emmanuel Eur. Fdn. for the Study of Chronic Liver Failure EASLnews

🌟 Exciting news from the Decision4Liver project! The first patient has been enrolled at Hôpital Beaujon, Clichy, France in the COMBAT Trial! This EU-funded Phase II clinical trial will explore a novel combinatorial therapy with albumin and enoxaparin for decompensated

It's out: The standard reference on 🩸portal vein thrombosis🩸 👉 diagnosis 👉 management 👉 endpoints for future clinical studies Chapeau Rautou Pierre-Emmanuel & team 🔗 authors.elsevier.com/c/1jO-d8nByrCi… #LiverTwitter The Lancet Gastroenterology & Hepatology

New Review - Elkrief et al - Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies thelancet.com/journals/langa… ERN RARE LIVER Valdig Group #LiverTwitter Rautou Pierre-Emmanuel

More than a review - Consensus on portal vein thrombosis - wonderful meeting in Paris and great paper! Congratulations to Laure Elkrief Rautou Pierre-Emmanuel and the whole team!

Mattias Mandorfer Rautou Pierre-Emmanuel The Lancet Gastroenterology & Hepatology Virginia Marco Senzolo Anna Baiges Annalisa Berzigotti JC Garcia Pagan Paradis valerie David Patch This a publication that all hepatologist should read. Congratulations to the authors and the VALDIG

The Lancet Gastroenterology & Hepatology Brett E Fortune MD ERN RARE LIVER Valdig Group Rautou Pierre-Emmanuel Just done reading this! What an amazing read! ❤️🔥

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies Amazing collective work 💪 Everything there is to know, and more! + a new set of imaging criteria to play with ⬇️ thelancet.com/journals/langa… Valdig Group Rautou Pierre-Emmanuel

Persistent Varices in Cured Patients: Understanding the role of Hepatic Venous Pressure Gradient - JHEP Reports jhep-reports.eu/article/S2589-…

Bravo Université Paris Cité Pr Emmanuel Ratou ! J'espère que nous pourrons aider/participer à RHU Liver-Track au Centre Hépato-Biliaire, Hôpital Paul Brousse AP-HP Université Paris-Saclay !

Our new Masterclass on YouTube: youtu.be/udVwtvyu2b0 👉Why + how to perform #EconomicEvaluations in liver disease? 👉What are #QALYs? 👉How are they calculated? Prof. Isabelle Durand-Zaleski from AP-HP knows the answers😀! European Liver Patients' Association Prof Rajiv Jalan HaDEA #LiverTwitter

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome. - Journal of Hepatology journal-of-hepatology.eu/article/S0168-… Proud of this collaborative effort. Thanks to all VALDIG, ERN centers Hospital Clínic IDIBAPS ERN RARE LIVER CIBERehd

Very proud and thankful to see this study on metabolomic profiles in cirrhosis and PSVD finally published. I am more than grateful for the team working on this project - especially Georg Semmler and Oleksandr Petrenko as well as our collaboration partners JC Garcia Pagan! 😀